Pendulum Therapeutics' Gut Fuel is a flavorless prebiotic fiber and polyphenol blend designed to seamlessly enhance foods and beverages to support the gut, digestion and overall health. This doctor-formulated superfood powder is useful not only to improve regularity but also to feed beneficial bacteria in the gut microbiome, which in turn supports the body's natural GLP-1 signaling pathways.
This powder is made with a combination of plant-based fibers and antioxidant-packed ingredients, including resistant potato starch, baobab, acacia, oat beta-glucan and grape seed extract. "Because it blends seamlessly into everyday foods, it turns virtually any meal into a superfood that closes the fiber gap and supports the microbiome," said Pendulum co-founder and CEO Colleen Cutcliffe, PhD.
Flavorless Gut Support Powders
Pendulum Therapeutics' Gut Fuel Nourishes GLP-1-Boosting Bacteria
Trend Themes
-
Flavorless Functional Powders — Neutral-tasting, nutrient-dense powders allow widespread incorporation of targeted health ingredients into everyday meals, enabling discreet personalization of diets at scale.
-
Microbiome-driven GLP-1 Modulation — By selectively feeding bacterial populations that influence GLP-1 signaling, formulations create a nutritional route to metabolic regulation that could rival pharmaceutical approaches.
-
Seamless Superfood Integration — Products designed to blend invisibly into diverse foods support habitual consumption patterns and open possibilities for mainstreaming clinical-grade nutrition outside of clinical settings.
Industry Implications
-
Nutraceuticals — Advanced prebiotic and polyphenol blends represent a shift toward clinically validated supplements that bridge the gap between food and medicine.
-
Food and Beverage Manufacturing — Incorporating flavorless functional ingredients into mass-market products presents opportunities for reformulating staples to deliver measurable health benefits without changing taste profiles.
-
Healthcare and Diabetes Care — Microbiome-focused nutritional therapies offer complementary pathways for glycemic and metabolic management that could alter standard therapeutic regimens.